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Abstract
Background: Traditionally, drug prescription and follow up have been the sole responsibility of physicians. However,
interprofessional medication reviews (IMRs) have been developed to prevent drug discrepancies and patient harm
especially for elderly patients with polypharmacy and multimorbidity. What participating nurses and pharmacists learn
from each other during IMR is poorly studied. The aim of this study was to investigate nurses’ and pharmacists’
perceived learning experience after participating in IMRs in primary health care for up to two years.
Methods: A qualitative study with semi-structured focus group interviews and telephone interviews with nurses and
pharmacists with experience from IMRs in nursing homes and home based services. The data was analysed
thematically by using systematic text condensation.
Results: Thirteen nurses and four pharmacists were interviewed. They described some challenges concerning how to
ensure participation of all three professions and how to get thorough information about the patient. As expected, both
professions talked of an increased awareness with time of the benefit of working as a team and the perception of
contributing to better and more individual care. The nurses’ perception of the pharmacist changed from being a
controller of drug management routines towards being a source of pharmacotherapy knowledge and a discussant
partner of appropriate drug therapy in the elderly. The pharmacists became more aware of the nurses’ crucial role of
providing clinical information about the patient to enable individual advice. Increasingly the nurses learned to link the
patient’s symptoms of effect and side effect to the drugs prescribed.
Conclusions: Although experiencing challenges in conducting IMRs, the nurses and pharmacists had learning
experiences they said improved both their own practice and the quality of drug management. There are some challenges
concerning how to ensure participation of all three professions and how to get thorough information about the patient.
Keywords: Medication review, Nurse, Pharmacist, Learning, Inappropriate drug use, Primary care
* Correspondence: hege.t.bell@nord.no
1Department of Pharmacy, Faculty of Health Sciences, Nord University,
Namsos, Norway
2Department of Public Health and General Practice, Norwegian University of
Science and Technology, Trondheim, Norway
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bell et al. BMC Family Practice  (2017) 18:30 
DOI 10.1186/s12875-017-0598-0
Background
Elderly living at home and in nursing homes use many
drugs [1] and are therefore at risk of experiencing adverse
drug reactions and increased risk of falls [2]. Physicians
have traditionally been responsible for drug prescription
and follow up, but it has e.g. been shown that they renew
prescriptions without assessing if the medication is still in-
dicated [3]. In addition frequent changes in caregivers
both between secondary and primary care but also within
primary care, make elderly patients and patients with
complex care needs more vulnerable to drug discrepan-
cies that can lead to drug errors [4]. As a result systems
for medication reconciliation and interprofessional medi-
cation reviews (IMRs) have been developed [5]. IMRs by
physicians, nurses and pharmacists have been showed to
reduce drug-related problems and improve quality of pre-
scribing in hospitals and nursing homes patients [6, 7].
Primary health care workers often face additional chal-
lenges compared to those working in a hospital setting
due to lack of geographical proximity of the team mem-
bers [8]. Facilitators and barriers to interprofessional col-
laboration in primary health care has been identified as
being both structural and cultural like the need of shared
facilities, written procedures, shared communication tools,
accessibility, trust, value and leadership [9, 10]. Collabor-
ation between nurses and community pharmacists in pri-
mary care concerns mainly product advice and dispensing
issues [11], but when nurses and pharmacists collaborate
in an inpatient medical setting they can learn to appreciate
each other’s roles [12].
The existing research on IMR has mainly focused on
the outcome of the intervention of the drug-related
problems [13] or the different participants’ perception of
the collaboration process [14]. However, we have found
no research focusing on what nurses and pharmacists
perceive to learn when participating in IMRs. The aim of
this study is therefore to describe what nurses and phar-
macists perceive to learn from participating in interpro-
fessional drug review teams in a primary health care
setting for up to two years.
Methods
This qualitative study is part of a larger study with focus
group and individual interviews performed between
October 2014 and February 2016 in Norway. The Re-
gional Committees for Medical and Health Research Eth-
ics in Central Norway approved the study (2014/1140).
Setting, training and practice
In Norway the municipalities are responsible for social
welfare and health care for all its inhabitants, including
home based health and social care and nursing homes
[15]. Part-time contracted general practitioners (GPs)
most commonly provide the medical services in nursing
homes [16] and the home dwelling elderly with home
based health and social care receive their medical service
from their GP with assistance from home care nurses
[17]. The nurses in home care services often work alone
as nurses, supported by staff with less or no formal nursing
education [18]. The majority of Norwegian pharmacists
work in privately owned community pharmacies or
hospital pharmacies. The municipalities have contracts
with a hospital or community pharmacy to provide ser-
vices to inspect drug management or to perform medi-
cation reviews [19].
Interprofessional medication reviews is not established
in primary health care in Norway, but since 2013 the GP
legislation states that patients prescribed four or more
drugs, the GP should perform medication reviews if this
is necessary from a medical point of view [20]. There is
yet no such legislation for patients in nursing homes. In
2011–13 the Norwegian Patient Safety Programme “In
safe hands” was implemented throughout Norway. Two
of the 12 focus areas were to establish interprofessional
teams on medication reviews in nursing homes and home
based health and social care services [21]. The centres for
Development of Institutional and Home Care Services
[22] in each of Norway’s 19 counties were responsible for
spreading the program to municipalities in their own
county, following a national guideline based on the Inter-
grated Medicines Management (IMM-model) [23].
The IMM-model consists of four main steps [23] and
is based upon the original version from Northern Ireland
[24]. In the first step, the nurses interview and go through
a checklist with the patient, order blood samples and con-
struct a drug list based on the available information. In
the second step, the nurses pass this information to the
pharmacist who identifies potential drug-related problems
and checks if the prescribing is according to national
guidelines. In the third step, the drug review is performed
at a case conference where the responsible physician,
nurse and the pharmacist meet and perform medication
reconciliations and reviews where they discuss the best
drug regime for that specific patient. The physician is re-
sponsible for the overall treatment. Finally, the nurse up-
dates information of the drug regime agreed upon in the
patient’s journal. They also observe how the patient re-
sponds to any changes and give feed back to the GP when
necessary [21]. The drug reviews require consent from the
patient that allows health information to be shared in be-
tween the three professions involved.
The municipalities were encouraged to form interpro-
fessional teams, consisting of at least one representative
from the three professions; physician, nurse and pharma-
cist. In a course consisting of three structured learning
meetings throughout one year the interprofessional teams
of health professionals, were introduced to the method-
ology in the IMM-model, introduction to why IMRs are
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useful for the elderly patient, encouraged to initiate inter-
professional cooperation and to establish interprofessional
medication reviews (IMRs) [25]. The interprofessional
teams were encouraged to start practicing medication rec-
onciliations and IMRs after the first meeting in the course
[21]. The nurses within each team were charged with de-
veloping local routines for the selection of eligible pa-
tients, routines for how to organize IMR-tasks on top of
everyday tasks, and how to book case conferences. They
were also responsible for spreading of knowledge on IMR
to their colleagues. Only two physicians from the 11 par-
ticipating municipalities attended the implementation
course and only at the first meeting. It was therefore up to
the team leaders, who were nurses, to recruit an appropri-
ate physician from their municipality to their team. In
some of the municipalities no physician was recruited and
the IMRs were performed with only nurse and pharmacist
present. In these teams the pharmacist first presented her
findings to the nurse who then gave her input before she
later was responsible of presenting the revised results
from the discussion to the physician.
Informants and data collection
We aimed to recruit physicians, nurses and pharmacists
who had participated in the patient safety program and
who had experience of performing IMR. To ensure a
representative sample, we wanted to have teams represent-
ing different municipality size, different length of experi-
ence with IMR and from both nursing homes and home
based health and social care. The reports given by the dif-
ferent teams after the course were used to select teams
based on these criteria.
To recruit informants, the appointed team leaders in
11 municipalities in Central Norway were contacted by
e-mail and then by phone. They were told that they
could volunteer teams even though not all team members
in each team wanted to participate. This approach only
lead to the recruitment of two pharmacists participating
in several teams each and therefore additional two phar-
macists were recruited through the hospital pharmacies in
the county.
The semi-structured focus group interviews were con-
ducted with representatives from all included teams 1–2
years after initiation of the course in their county. Focus
group is particularly useful for exploring people’s com-
mon experiences, attitudes and views in environments
where people interact. The use of group interaction is an
explicit part of the method [26]. The focus group inter-
views were either conducted at a nursing home or at the
city hall in the municipality. An interview guide with
open-ended questions focused on the following themes
was used; perceived learning and gained knowledge in
addition to perceived facilitators and barriers to be able
to perform interprofessional medication reviews in
primary health care [27] (Additional file 1). The focus
group interviews lasted approximately one and a half
hour, were digitally recorded and led by the first author
(HTB). The telephone interviews lasted approximately
20 min performed by the first author using the same inter-
view guide. Participants were provided with written and
oral information about the study and informed that they
could withdraw at any time. Written informed consent
was obtained from the participants before the interviews
were conducted.
Data analysis
The interviews were digitally recorded and transcribed ver-
batim. They were analysed using the method of systematic
text condensation [28], according to an iterative four-step
process. In the first step, all authors read a selection of the
transcripts to identify preliminary themes, which were dis-
cussed. In the second step, the transcripts were searched in
detail by the first author to identify meaning units, which
were sorted under the preliminary themes and these were
presented to the other authors. In the third step, the mean-
ing units were arranged into subthemes. In all these steps
the preliminary themes were adjusted. Then a narrative
condensate was made of the meaning units sorted under
each theme and subtheme. In the last step, an analytic text
was produced based upon each theme and subtheme. The
themes and the analysis were discussed among the authors
several times and also in an extended research group to en-
sure validity. During the whole process, the authors went
back to the original transcripts to ensure that the analysis
was based upon them.
Results
A total of thirteen nurses from five different nursing homes
and three home-based care units and four pharmacists
were interviewed. There were three focus group interviews
consisting of nurses only but from both nursing homes
and home based care, and two with nurses from different
workplaces and a pharmacist. The remaining two pharma-
cists were interviewed by telephone. Further participant
characteristics are presented in Table 1.
The perceived learning from participating in structural
interprofessional medication reviews in primary health
care are arranged in the following five themes; Learning
about each other’s role, A more comprehensive documen-
tation of drug management, Challenge the physician’s role,
Importance of detailed information about each patient
and Linking patient’s symptoms and medication use.
Learning about each other’s role
It was new for the nurses in the nursing home and home
based health and social care to learn during the interpro-
fessional medication reviews (IMRs) that pharmacists
could provide advice and guidance on appropriate drug
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use for the elderly patients. This was contrary to their
previous experience of pharmacists as someone who
came on irregular visits and primarily focused on con-
trolling their drug management routines. After taking
part in IMRs, however, they now perceived the pharma-
cist as a supportive partner who could give them useful
advice on pharmacology and pharmacotherapy. They es-
pecially appreciated the pharmacists’ knowledge con-
cerning drug monitoring data for laboratory values like
haematology, proteins, hormones, vitamins and drugs
such as digoxin with a small therapeutic window. The
pharmacists said that after the establishment of the
IMR-teams, the number of telephone and e-mail in-
quires from both nurses and physicians regarding drug
therapy questions had increased.
The pharmacists gave us a very good impression by
showing how much they could contribute regarding
knowledge on drugs and drug therapy. They knew
much more than we thought they did. Our previous
impression was that they sold plasters and handled
the drugs at the pharmacies. (Nurse, less than one
year of experience with IMR)
The pharmacists did not meet with the patients them-
selves and therefore talked about a dependency on the
patient information given by the nurses. Preparing for
the IMRs could be challenging for the pharmacists when
not having access to updated drug monitoring data and
complementary patient documentation. They perceived
the majority of the nurses to provide good information
and documentation, but there were also examples of the
contrary like e.g. nurses who did not know the patient
well.
“A case has many sides and I only know the patient
through his drug list. So it is very important for me to
get the additional information from the nurses. Like
when a patient has pain. When does he have pain and
what type of pain?” (Pharmacist, more than 2 years
experience of IMR)
A more comprehensive documentation of drug
management
Taking part in the IMR, the nurses talked about how
they learned to become more critical towards their own
drug management routines and talked about a raised
awareness on better documentation of these routines in
everyday work. In addition, especially the nurses working
in home based health and social care, learned the im-
portance of medication reconciliation that ensured an
updated list of drugs in use due to the high number of
carer that could be involved. An updated drug list which
they trusted to be correct also helped them to get a
more complete and documented overview of the patient’s
medical situation and to later link this to the drugs in use.
When the other professions regarding drug manage-
ment raised challenging questions the nurses said they
learned the need for accurate, updated and detailed in-
formation in the patient journals about drugs in use and
the need for a broader focus on drug management as a
whole. This included having all the patient’s diagnosis
listed in the journal and to ensure written indications for
the different drugs to be available for all health personnel
involved with the patients. Participating in IMRs were
therefore said to promote an understanding of compre-
hensive documentation of the drug management as a
nurse task just as important as the other nursing tasks. It
was highlighted that staff without any formal nursing edu-
cation, who often are the ones to hand out the drugs and
spend most time with the patients, especially appreciated
this quality improvement.
“In the beginning when the indications were vague and
not always written on the patient’s medicine card it
was difficult to evaluate the usefulness of the drugs.
Especially since it was not written why they were put
on those drugs.” (Nurse, less than one year of
experience of IMR)
Challenge the physician’s role
The nurses with experience of performing IMRs to-
gether with both a physician and a pharmacist said that
the pharmacist challenged the physician’s role as the
only drug expert. In particular this involved posing other
types of questions, comments and solutions than the
nurses did. This was said to stimulate the physicians to
reflect upon their previous drug prescribing and in some
instances forced the physicians to argue their case when
Table 1 Participant characteristics
Nurses
(n = 13)
Pharmacists
(n = 4)
Working in nursing homes 8 -
Rural 5 3
Urban 3 4
Working in home-based care 5 -
Rural 2 -
Urban 3 -
≤1 year experience of performing IMR
in primary health care
5 1
>1 year experience of performing IMR
in primary health care
8 3
Experience from performing IMR in hospital - 3
Experience of performing IMR with a
physician present
10 4
Experience of performing IMR without a
physician present
3 3
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there where disagreements. Both professions perceived
disagreements as strength for the quality of drug therapy
for the patients, because it triggered the physician to re-
view the drug therapy choices initiated by themselves or
other prescribers. Some nurses felt that the pharmacists’
questions echoed comments and questions previously
raised by themselves to the physicians, but where they
hitherto had failed to argue their case or gave in without
getting a clear answer. However, when the pharmacists
asked questions during the team discussions the physi-
cians responded better and more clearly.
“The pharmacist sees it from another angel and uses
her own specialist knowledge to come up with new
alternatives that the physician has not thought of – as
far as I can see that must increase the quality.”
(Nurse, with more than one year experience of IMR)
The nurses that had performed IMRs without having a
physician present did not compliment the pharmacist in
the same way and said that the physician was the one
who knew what was best for the patient regardless the
pharmacist’s suggestions. These nurses sometimes per-
ceived the physicians as headstrong but it was also em-
phasized that the physicians often had long experience
in the municipality and therefore had a better insight
into the totality of the patient’s situation. In some of the
cases the experience was also that when the nurses pre-
sented the suggestions to the physicians after the IMR
with the pharmacist the physician rarely if at all took the
suggestions into account.
“We presented it to the physician. And since they were
only suggestions he did not go for them.” (Nurse, with
less than one year of experience of IMR and IMR
without physician)
The pharmacists that had experienced IMR without a
physician appreciated the nurse’s contribution during
the drug review, but found it unsatisfactory not being
able to discuss and argue their case directly with the
physician. Not knowing whether their suggestions were
followed were also highlighted as a disadvantage since
they perceived to learn less when missing out the discus-
sions with the physician in particular. When the phys-
ician was present the pharmacists perceived that the
physicians in the majority of the cases appreciated their
contributions, but there were also experience of the con-
trary. With time the pharmacists said to understand bet-
ter why their theoretical grounded suggestions not
always were accepted by the physicians, mainly due the
physicians’ knowledge of a larger totality of the patients’
situation than themselves. This was said to contribute to
a wider understanding of some of the choices taken by
the primary care physician and to enable the pharma-
cists to view a case from another perspective than they
usually did.
“We get the physicians view of the patient. A GP know
the patient and his history better than I do and I
might suggest a change that might have been tried out
before (…) which the physician find difficult to
implement (…) because the patient might refuse.”
(Pharmacist, more than 2 years experience of IMR)
Importance of detailed information about each patient
In some municipalities the pharmacists experienced that
the nurses struggled to find time to do their part of the
preparatory work, such as interviewing the patient, order
drug monitoring blood samples and filling in the patient
checklist. This resulted in delayed or deficient documen-
tation to the pharmacist. These drug reviews were per-
ceived as unsatisfactory since the pharmacist then only
could give generic advice and not tailor the suggestions
for the patient in question.
“The advices we give might be good, but it might not
be the best for that specific patient. For example I set
up an optimal list of drugs based upon the guidelines,
but then maybe the patient is not able to swallow
tablets or remember to take the tablets twice a day.
There is a lot of extra information I need to be able to
set up an appropriate list of drugs.” (Pharmacist, more
than 2 years experience of IMR)
As a consequence, one pharmacist had changed the
preparing routines prior the IMR and now spent the
whole day at the nursing home or home based health
care. Information about the patient were gathered and
collected by the pharmacist using information from the
patient’s journals and talking to the nurses. The prepara-
tions took place in the morning and then the IMR was
performed in the afternoon. This was said to give a bet-
ter access to the existing documentation and also gave
the pharmacists the opportunity to ask the nurses and
other staff of supplementary information when needed.
None of the drug reviews were performed with the pa-
tient present. Perceiving themselves as the patient’s voice
at the drug review made the nurses discover that detailed
knowledge of each patient was a necessity to be able to
answer questions raised by the other two professions at
the IMR. Contrary, the nurses felt awkward when present-
ing patients they did not know well or relied on second
hand information. Good cooperation with nursing assis-
tants or other care workers was perceived as important
when collecting necessary information on function level
and behaviour. Likewise, it was said to be important to
discuss the observations of each patient in the nurse
Bell et al. BMC Family Practice  (2017) 18:30 Page 5 of 9
collegium since different persons perceived the patients
differently. This was especially important in home based
health care service as opposed to nursing homes, because
the nurses spend only a short time with domiciliary
patients.
It was also expressed as difficult to convey patient in-
formation, when the nurse interviewing and collecting
the information about the patient might not be the same
presenting at the drug review. The teams that perceived
good backing for the IMR tasks in the municipality and
who had managed to develop good routines throughout
the collegium were also those who found collecting
these data least difficult.
“I felt sometimes – oh I should have known more
about this patient. I do not believe that I will be the
one that continues performing drug reviews.” (Nurse,
less than one year experience of IMR)
Linking patient’s symptoms and medication use
The pharmacists experienced that the nurses gradually
showed a deeper engagement for the medication reviews,
such as being more updated on the patients’ conditions,
symptoms and the prescribed drugs. The nurses said that
during the medication reviews they had learned new
things about pharmacotherapy, especially how drugs work
and drug-drug interactions. Examples were knowledge
about drugs with anticholinergic effect and drugs that can
increase the risk of falls in their patients.
“We have learned more about combination of different
drugs and anticholinergic effects. (…) Being more
aware on pain relief – the need to assess the treatment
more often and at an earlier stage. Previously they
had Paracetamol 1 g x 3 without us assessing, but now
we ask them whether they still need them. The
questions pop up more frequently.” (Nurse, more than
one year experience of IMR)
A stronger knowledge on pharmacotherapy made the
nurses more observant and capable of interpreting pa-
tients’ behaviour possibly linked to the drug use – both
effects and side effects. They said that they became more
curious and critical, therefore asking more questions to
the physicians and pharmacists. They also became more
aware of the need for a more comprehensive documen-
tation of the drug management. New awareness was said
to be transferrable to other patients not yet part of IMRs
such as assessing drug therapy at an earlier stage, for ex-
ample in long-term pain treatment. Participation in IMR
with both pharmacist and physician heighten their
awareness on drug treatment as a whole and were said
to contribute to the perception of more individual care.
“We have gained a greater awareness on drugs (…)
You become a little more aware when you see a drug
sheet. “Can this be correct?” (…) You become more
critical.” (Nurse, with more than one year experience
of IMR)
When asked if the learning emerged from participating
in the course or from performing IMR, both the profes-
sions linked the learning to active participation in IMRs.
They said that at a course you were only a passive recipi-
ent, whereas during IMR you had to use your adopted
knowledge actively which again led to learning. Arguing
their case was particularly highlighted to contribute to
learning. The nurses who had performed IMRs without
a physician present spoke less of what they had learned
during this period.
“I believe that IMR give something extra since you
have to use what you know actively. You get forced to
think through what you are doing. Why do we do this
IMR, and you look at the check list and think of the
patient’s drugs and how the whole situation is for the
patient.” (Nurse, more than one year experience of IMR)
Discussion
In this study it was found that both professions reported
to learn more about each other’s role when performing
interprofessional medication reviews (IMRs). The nurses’
perception of the pharmacist changed from being a con-
troller of drug management routines towards being a
source of pharmacotherapy knowledge and a discussant
partner for appropriate drug therapy in the elderly. The
pharmacists became more aware of the nurses’ crucial
role of providing clinical information about the patient
to enable individual advice. Increasingly the nurses
learned to link the patient’s symptoms to the prescribed
drugs due to having learned more about pharmacology
and pharmacotherapy and also the importance of com-
prehensive drug management and detailed information
about each patient. With time both professions jointly
spoke of an increased awareness of the benefit of work-
ing as a team and the perception of contributing to bet-
ter and more individual care. Through this they learned
to challenge the physicians’ knowledge and prescribing
decisions. IMRs were found to be unsatisfactory without
the physician’s input and without thorough information
about the patient’s condition.
Learning from each other and the experience of mutual
interdependence
Others have found that pharmacists can have other roles
than controlling and checking up on the other professions’
drug handling [29] and that other professions’ awareness
of the pharmacists’ clinical skills increases with time
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[12, 30]. This is in line with our findings. The most
prominent learning reported by the informants in this
study was how they came to appreciate each other’s
role during the medication reviews and how this cre-
ated a sense of mutual interdependence. Participating
in IMR were said to lift the focus on medication man-
agement as an important nurse task and that the phar-
macists’ contributions during the IMRs elevated the
nurses’ own performance. Nurses and physicians have
both stated a perceived elevation of performance and
educational benefit from working together with phar-
macists [12].
It has been found that effective teamwork demands
role clarity and an understanding of roles and responsi-
bilities [8, 31], where working together can create a
sense of mutual interdependence when different profes-
sions learn to know each other’s roles [32]. Pharmacists
cooperating with other professions have been shown to
facilitate a team approach that improved the patient’s
drug related outcomes [12, 30]. This is in line with our
study. The discussions during the IMRs where all profes-
sions were present were especially perceived as beneficial
and therefor indicate that doing IMRs together can con-
tribute to both learning and the perception of mutual
interdependence.
Challenges when applying IMRs in primary health care
Lack of mandate for the pharmacist’s role [10], the time
the pharmacist was on site and funding of the pharma-
cists [14] has been found as barriers for pharmacists par-
ticipating in interprofessional teams in primary health
care. The model of IMM provides guidelines for the role
of the pharmacists in IMRs [23], but the funding is
dependent on the municipalities’ willingness to pay for
the pharmacist and can be a limitation for the continu-
ation of IMRs in primary care. Our findings also concur
with findings in studies from Supper et al. and Bell et al.
which found that limited access to the complete medical
history and relevant monitoring data can be perceived as
a barrier for the pharmacist [10, 33]. In our study it was
particularly evident that the main barrier was if there
were delayed or deficient documentation about the pa-
tient’s condition given to the pharmacist prior to the
IMRs.
The physician has a pivotal role in decisions making
about the prescribed medicines [34]. No surprise, when
the physician is not present at the IMR, the interviewees
said that they learned less. Accessibility has been shown
to be a premise for interprofessional collaboration par-
ticularly between physicians and allied health profes-
sionals [9]. Not having all professions present is also a
deviation from the IMM-model [24]. When team mem-
bers have separate bases or buildings they are less inte-
grated with the team [8]. However, it was perceived as
challenging to gather all professions for joint meetings
in primary care. The same was found in studies of inter-
professional cooperation in family health teams and fam-
ily medicine clinics that describe challenges according to
management, leadership, time, space and governance
[32, 35]. Thus, there seems to be a need for innovative
solutions to overcome obstacles such as finding common
time and booking meeting facilities for the case confer-
ences, in home based care and in rural municipalities.
Another challenge experienced by our informants was
how to ensure good and correct information about each
patient. Shift work and part-time positions in addition to
nurses spending little time with home dwelling patients,
made it difficult to collect the relevant patient informa-
tion. Thus it can be a challenge to gather and collect com-
prehensive and objective information about the patient
from all personnel involved prior to the medication re-
views. This raises the question whether the patients
themselves, unlike today [34], should be present during
IMR to make sure that the patients’ perspectives are
taken into account. From an ethically perspective pa-
tients should be included in decisions about their own
care [36]. We have, however, not found any studies in-
vestigating such a solution in IMRs.
Medication management in primary care – more than
right medicine to right patient
Since service users in primary care receive lower level of
medical service intensity compared to hospital patients,
the need to observe, document and report effects of the
medical treatment has been reported to be an even more
crucial task for the nurses [37, 38]. This includes moni-
toring medication administration, adherence and the ef-
fect medicines have on patients’ symptoms [39]. The
findings in this study indicates that this could be prob-
lematic due to the infrequent contact with the patient in
home based care and not being challenged to report spe-
cifically on these issues. It is therefore reassuring that
the IMR was experienced as an arena where the nurses
became more aware of the importance of thorough
medication handling routines and a need for written
high quality instructions on all the steps in the medica-
tion management process.
Strengths and limitations
The strength of this study was that the informants had
real life experience with doing interprofessional medica-
tion reviews over time and the variation in the clinical
situations the IMRs were conducted. In addition, there
were variation in geography and population. It was a
limitation that the interviewees came from one county
in Norway and none of the municipalities were a large
city. However, as others have similar findings [12, 30]
this does not seem to limit the transferability. The lack
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of the physicians as informants is another limitation.
The physicians were invited on equal terms as the other
two professions, but none of the physicians involved
responded to the invitation. There is therefore a need
for studies in the physicians’ perspectives but also on the
patients’ perspective.
The focus groups purposefully consisted of teams that
had participated in the course and performed medication
reviews together. This contributed to a relaxed and freely
speaking environment. Former disagreements could have
limited discussions of topics they knew could cause dis-
agreement and even hamper future collaboration. Further-
more, the fact that HTB is a pharmacist could have
limited criticism of the pharmacists’ role. However, the re-
view of the transcripts indicates that the interviewees
spoke also about disagreements during the interviews.
From the interviews, it seemed like the nurses learned
more from the pharmacists than the other way around.
This is likely to be due to the predominance of nurses
among the informants, but it might also be due to the
nurses getting access to a new profession’s knowledge
and skills, which was unlike the pharmacists whom the
majority had former experience from IMR in hospitals.
Conclusion
From the nurses’ and pharmacists’ perspective in this
study, IMRs in primary health care can be a learning
arena for the participating professions. It was experienced
to contribute to improving their own practice and the
quality of drug management, resulting in better and more
individualised care. There are some challenges especially
concerning how to ensure participation of all three profes-
sions and how to get thorough information about the
patient.
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